Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 8
2022 13
2023 18
2024 19
2025 18
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence and inflammatory bowel disease: Where are we going?
Da Rio L, Spadaccini M, Parigi TL, Gabbiadini R, Dal Buono A, Busacca A, Maselli R, Fugazza A, Colombo M, Carrara S, Franchellucci G, Alfarone L, Facciorusso A, Hassan C, Repici A, Armuzzi A. Da Rio L, et al. Among authors: dal buono a. World J Gastroenterol. 2023 Jan 21;29(3):508-520. doi: 10.3748/wjg.v29.i3.508. World J Gastroenterol. 2023. PMID: 36688019 Free PMC article. Review.
Drug Development in Inflammatory Bowel Diseases: What Is Next?
Petronio L, Dal Buono A, Gabbiadini R, Migliorisi G, Privitera G, Ferraris M, Loy L, Bezzio C, Armuzzi A. Petronio L, et al. Among authors: dal buono a. Pharmaceuticals (Basel). 2025 Jan 30;18(2):190. doi: 10.3390/ph18020190. Pharmaceuticals (Basel). 2025. PMID: 40006003 Free PMC article. Review.
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies.
Bezzio C, Cavalli CAM, Franchellucci G, Dal Buono A, Gabbiadini R, Scalvini D, Manara S, Narcisi A, Armuzzi A, Saibeni S. Bezzio C, et al. Among authors: dal buono a. Therap Adv Gastroenterol. 2024 Nov 21;17:17562848241299564. doi: 10.1177/17562848241299564. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39575159 Free PMC article.
Juvenile polyposis syndrome: An overview.
Dal Buono A, Gaiani F, Poliani L, Laghi L. Dal Buono A, et al. Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101799. doi: 10.1016/j.bpg.2022.101799. Epub 2022 Apr 4. Best Pract Res Clin Gastroenterol. 2022. PMID: 35988962 Free article. Review.
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial.
Ortiz O, Daca-Alvarez M, Rivero-Sanchez L, Gimeno-Garcia AZ, Carrillo-Palau M, Alvarez V, Ledo-Rodriguez A, Ricciardiello L, Pierantoni C, Hüneburg R, Nattermann J, Bisschops R, Tejpar S, Huerta A, Riu Pons F, Alvarez-Urturi C, López-Vicente J, Repici A, Hassan C, Cid L, Cavestro GM, Romero-Mascarell C, Gordillo J, Puig I, Herraiz M, Betes M, Herrero J, Jover R, Balaguer F, Pellisé M; TIMELY study group. Ortiz O, et al. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):802-810. doi: 10.1016/S2468-1253(24)00187-0. Epub 2024 Jul 19. Lancet Gastroenterol Hepatol. 2024. PMID: 39033774 Free article. Clinical Trial.
JAK selectivity: more precision less troubles.
Roda G, Dal Buono A, Argollo M, Danese S. Roda G, et al. Among authors: dal buono a. Expert Rev Gastroenterol Hepatol. 2020 Sep;14(9):789-796. doi: 10.1080/17474124.2020.1780120. Epub 2020 Jun 16. Expert Rev Gastroenterol Hepatol. 2020. PMID: 32520647 Review.
How comparative studies can inform treatment decisions for Crohn's disease.
Privitera G, Bezzio C, Dal Buono A, Gabbiadini R, Loy L, Brandaleone L, Marcozzi G, Migliorisi G, Armuzzi A. Privitera G, et al. Among authors: dal buono a. Expert Opin Biol Ther. 2024 Sep;24(9):955-972. doi: 10.1080/14712598.2024.2389985. Epub 2024 Aug 12. Expert Opin Biol Ther. 2024. PMID: 39132872 Review.
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer.
Paiella S, Capurso G, Carrara S, Secchettin E, Casciani F, Frigerio I, Zerbi A, Archibugi L, Bonifacio C, Malleo G, Cavestro GM, Barile M, Larghi A, Assisi D, Fantin A, Milanetto AC, Fabbri C, Casadei R, Donato G, Sassatelli R, De Marchi G, Di Matteo FM, Arcangeli V, Panzuto F, Puzzono M, Dal Buono A, Pezzilli R, Salvia R, Rizzatti G, Casadio M, Franco M, Butturini G, Pasquali C, Coluccio C, Ricci C, Cicchese N, Sereni G, de Pretis N, Stigliano S, Rudnas B, Marasco M, Lionetto G, Arcidiacono PG, Terrin M, Crovetto A, Mannucci A, Laghi L, Bassi C, Falconi M. Paiella S, et al. Among authors: dal buono a. Am J Gastroenterol. 2024 Apr 1;119(4):739-747. doi: 10.14309/ajg.0000000000002546. Epub 2023 Oct 3. Am J Gastroenterol. 2024. PMID: 37787643
79 results